Contact allergy to topical ophthalmic medications: A retrospective single‐centre study of three decades
Fuente:
Wiley Open Access
Saved in:
| Main Authors: | , , |
|---|---|
| Format: | Artículo Open Access |
| Published: |
Wiley
2024
|
| Subjects: | |
| Online Access: | |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1867008010921967616 |
|---|---|
| author | Sebastian Vigand Svendsen Charlotte G. Mortz Kristian Fredløv Mose |
| author_facet | Sebastian Vigand Svendsen Charlotte G. Mortz Kristian Fredløv Mose Sebastian Vigand Svendsen Charlotte G. Mortz Kristian Fredløv Mose |
| collection | Wiley Open Access |
| contents | Contact allergy to topical ophthalmic medications: A retrospective single‐centre study of three decades Sebastian Vigand Svendsen Charlotte G. Mortz Kristian Fredløv Mose Contact Dermatitis AbstractBackgroundThe prevalence of contact allergy to various ophthalmic medications appears to be rare; however, data on culprits, clinical relevance of sensitizations, and changes in frequency within recent decades are limited.ObjectiveThis study aimed to investigate the clinical relevance, risk factors, and prevalence of contact allergy to topical ophthalmic medications in patients suspected of allergic contact dermatitis to ophthalmic medication.MethodsWe retrospectively analysed patch test results and clinical data for 754 patients patch‐tested with an ophthalmic medication series at our tertiary referral centre between January 1992 and December 2022.ResultsIn total, 37.5% (283/754) of patch‐tested patients had a contact allergy to at least one ophthalmic allergen, with 87.3% (247) being clinically relevant sensitization. Phenylephrine (31.8%, 192/604), povidone‐iodine (29%, 27/93), and tobramycin (23%, 46/200) were the most important sensitizers. The incidence of contact allergies increased significantly in a linear manner (p = 0.008) from 20% to 44.1% within the study period. Male sex and age above 40 were risk factors for contact allergy to ophthalmic medication.ConclusionsOne third of patch tested patients had allergic contact dermatitis to ophthalmic medication, particularly phenylephrine. Male sex and age above 40 years were independent risk factors and drove the linear increase in contact allergy to ophthalmic medications within the past 31 years. 10.1111/cod.14552 http://creativecommons.org/licenses/by-nc-nd/4.0/ |
| doi_str_mv | 10.1111/cod.14552 |
| format | Artículo Open Access |
| id | wiley_oa_10_1111_cod_14552 |
| institution | Wiley Open Access |
| license_str_mv | http://creativecommons.org/licenses/by-nc-nd/4.0/ |
| publishDate | 2024 |
| publisher | Wiley |
| record_format | wiley_oa |
| spellingShingle | Contact allergy to topical ophthalmic medications: A retrospective single‐centre study of three decades Sebastian Vigand Svendsen Charlotte G. Mortz Kristian Fredløv Mose Contact Dermatitis Contact allergy to topical ophthalmic medications: A retrospective single‐centre study of three decades Sebastian Vigand Svendsen Charlotte G. Mortz Kristian Fredløv Mose Contact Dermatitis AbstractBackgroundThe prevalence of contact allergy to various ophthalmic medications appears to be rare; however, data on culprits, clinical relevance of sensitizations, and changes in frequency within recent decades are limited.ObjectiveThis study aimed to investigate the clinical relevance, risk factors, and prevalence of contact allergy to topical ophthalmic medications in patients suspected of allergic contact dermatitis to ophthalmic medication.MethodsWe retrospectively analysed patch test results and clinical data for 754 patients patch‐tested with an ophthalmic medication series at our tertiary referral centre between January 1992 and December 2022.ResultsIn total, 37.5% (283/754) of patch‐tested patients had a contact allergy to at least one ophthalmic allergen, with 87.3% (247) being clinically relevant sensitization. Phenylephrine (31.8%, 192/604), povidone‐iodine (29%, 27/93), and tobramycin (23%, 46/200) were the most important sensitizers. The incidence of contact allergies increased significantly in a linear manner (p = 0.008) from 20% to 44.1% within the study period. Male sex and age above 40 were risk factors for contact allergy to ophthalmic medication.ConclusionsOne third of patch tested patients had allergic contact dermatitis to ophthalmic medication, particularly phenylephrine. Male sex and age above 40 years were independent risk factors and drove the linear increase in contact allergy to ophthalmic medications within the past 31 years. 10.1111/cod.14552 http://creativecommons.org/licenses/by-nc-nd/4.0/ |
| title | Contact allergy to topical ophthalmic medications: A retrospective single‐centre study of three decades |
| topic | Contact Dermatitis |
| url | https://onlinelibrary.wiley.com/doi/10.1111/cod.14552 |